Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine used for treating coronary heart disease caused by stagnation of phlegm

A technology for phlegm congestion and coronary heart disease, applied in the field of pharmacy, can solve problems such as damage to the digestive system, and achieve the effects of high safety, good clinical efficacy, and long duration of efficacy

Inactive Publication Date: 2016-03-30
贾旭升
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Patients with coronary heart disease need to insist on taking long-term drugs to alleviate the condition of coronary heart disease and avoid various acute attacks. Long-term drugs such as nitroglycerin (such as nitroglycerin, etc.) can also be used for long-term treatment of coronary heart disease, generally starting from a small dose, taking sooner or later , with an interval of 8-12 hours, aspirin can reduce complications such as vascular embolism, but long-term use will cause damage to the digestive system

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] Embodiment 1 decoction

[0040] The embodiment of the present invention provides a medicine for treating phlegm obstructive coronary heart disease. 20 parts by weight of aster, 17 parts by weight of buckwheat, 15 parts by weight of saponins, 18 parts by weight of calamus, 17 parts by weight of styrax, 16 parts by weight of benzoin, 18 parts by weight of monkey dates and 4 parts by weight of kelp;

[0041] Its preparation method is specifically:

[0042] Step 1: Put the other raw materials and medicinal materials mentioned above into the purple casserole except the green stone, add clear water, until the clear water soaks the upper surface of the medicinal materials by 4 cm, and soak for 4 hours;

[0043] Step 2: Put the purple casserole pot on the fire, boil it with strong fire, then switch to slow fire for 40 minutes, filter to get the filtrate a, set aside;

[0044] Step 3: Put the green stone into the gauze bag and the remaining medicinal residues, add water again,...

Embodiment 2

[0045] Embodiment 2 drop pills

[0046] The embodiment of the present invention provides a medicine for treating phlegm obstructive coronary heart disease. 20 parts by weight of aster, 17 parts by weight of buckwheat, 15 parts by weight of saponins, 18 parts by weight of calamus, 17 parts by weight of styrax, 16 parts by weight of benzoin, 18 parts by weight of monkey dates, 4 parts by weight of green stone, 21 parts by weight of chicken tendon ginseng Parts by weight, 7 parts by weight of Golden Rod Hammer and 15 parts by weight of Chickweed;

[0047] Its preparation method is:

[0048] (1) Weigh and mix all raw materials and medicinal materials except sapphire by weight, add water and decoct 3 times, 2 hours each time, add 8 times the amount of water each time, filter the decoction, and combine the filtrations of each time liquid, concentrated, dried, and pulverized, then added ethanol with an alcohol concentration of 90% until the alcohol content was 45%, let it stand for...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine used for treating the coronary heart disease caused by stagnation of phlegm. The medicine comprises the following raw medicinal materials: chives, longstamen onion bulb, pepperweed seed, tatarian aster root, buckwheat, Chinese honeylocust spine, grass leaf sweetflag rhizome, storesin, benzoin, rhesus macaque bezoar and lapis chloriti. The medicine has the beneficial effects that the medicine is used for specially treating the coronary heart disease caused by stagnation of phlegm by utilizing the traditional theory of traditional Chinese medicine in China and has the advantages of good clinical curative effects, long curative effect duration, high safety, no toxic or side effect, and the like.

Description

technical field [0001] The invention relates to the technical field of pharmacy, in particular to a medicine for treating phlegm obstructive coronary heart disease. Background technique [0002] Coronary heart disease is a heart disease caused by atherosclerotic lesions in the coronary arteries that cause stenosis or blockage of the vessel lumen, resulting in myocardial ischemia, hypoxia or necrosis. The clinical manifestation is chest pain. Sudden precordial pain induced by physical activity, emotional agitation, etc. is mostly episodic colic or squeezing pain, and it can also be a feeling of depression. The pain starts from the back of the sternum or the front of the heart, and radiates upward to the left shoulder, arm, and even the little finger and ring finger. It can be relieved by rest or taking nitroglycerin. The part where the chest pain radiates can also involve the neck, jaw, teeth, abdomen, etc. Chest pain can also occur in a quiet state or at night, caused by...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/8962A61P9/10A61K35/413A61K33/26
CPCA61K9/0095A61K9/2063A61K33/26A61K35/413A61K36/185A61K36/28A61K36/31A61K36/483A61K36/70A61K36/888A61K36/8962A61K2300/00
Inventor 贾旭升公蕾
Owner 贾旭升
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products